A study by Jin et al. (2019), explored the implications of GLUT5 in clear cell renal cell carcinoma (ccRCC), exploring its influence on the malignancy’s progression through fructose utilization and its viability as a therapeutic target. The gene discussed is SLC2A5; the disease is nonpapillary renal cell carcinoma.